Detalhe da pesquisa
1.
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.
Lancet
; 395(10237): 1613-1626, 2020 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32580883
2.
One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.
Health Technol Assess
; 27(25): 1-176, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37991196
3.
Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study.
BJU Int
; 96(1): 48-53, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15963119